Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 121, Issue 5, 1999, Pages 534-538

  Bradford, C R ^a   Wolf, G T ^a   Carey, T E ^a   Zhu, S ^a   Beals, T F ^a   Truelson, J M ^a   McClatchey, K D ^a   Fisher, S G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLINE; DNA; FLUOROURACIL; PROTEIN P53;

ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; ORGAN PRESERVATION; PREDICTION; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032735478     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(99)70052-5     Document Type: Article

References (13)

1. C Jacobs DR Goffinet L Goffinet Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer Cancer 60 1987 1178 1183
2. IW Dimery AM Kramer AJ Choksi Neoadjuvant chemotherapy and radiotherapy in larynx preservation Am J Clin Oncol 12 1989 173 177
3. S Urba GT Wolf Organ preservation in multimodality therapy of head and neck cancer Hematol Oncol Clin North Am 5 1991 713 725
4. GT Wolf WK Hong S Fisher Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685 1690
5. JL Lefebvre D Chevalier B Luboinski Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899
6. GT Wolf WK Hong Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role? Head Neck 17 1995 279 283
7. J Bourhis G Wilson P Wibault Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer Laryngoscope 104 1994 468 472
8. GT Wolf TE Carey Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma J Natl Cancer Inst Monogr 13 1992 67 74
9. CR Bradford S Zhu GT Wolf Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer Otolaryngol Head Neck Surg 113 1995 408 412
10. CM Gregg TE Beals KM McClatchey DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma Otolaryngol Head Neck Surg 108 1993 731 737
11. PA Jakobsson Histologic classification and grading of malignancy in carcinoma of the larynx Acta Radiol 12 1973 1 8
12. JM Truelson SG Fisher TE Beals DNA content with histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx Cancer 70 1992 56 62
13. MB Spaulding SG Fisher GT Wolf Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma J Clin Oncol 12 1994 1592 1599